{"id":123028,"date":"2021-12-07T10:17:16","date_gmt":"2021-12-07T10:17:16","guid":{"rendered":"https:\/\/ccs.ca\/?page_id=123028"},"modified":"2024-06-05T10:37:48","modified_gmt":"2024-06-05T14:37:48","slug":"ccs-bms-hypertrophic-cardiomyopathy-hcm-research-award","status":"publish","type":"page","link":"https:\/\/ccs.ca\/ccs-research-awards\/ccs-bms-hypertrophic-cardiomyopathy-hcm-research-award\/","title":{"rendered":"CCS-BMS HCM Research Award"},"content":{"rendered":"\n
\"\"<\/figure>\n\n\n\n

The Canadian Cardiovascular Society and Bristol Myers Squibb (BMS) are proud to support the CCS-BMS Hypertrophic Cardiomyopathy (HCM) Research Award. The purpose of this award is to foster growth of peer-reviewed Canadian research in the area of HCM, with a focus on HCM diagnosis, progression monitoring, epidemiology and \/ or prevalence.<\/p>\n\n\n\n

Application Deadline: Closed for 2024<\/strong><\/strong><\/b><\/span><\/mark><\/strong><\/p>\n\n\n\n

\n
\n
\n
Apply Now<\/a><\/div>\n<\/div>\n<\/div>\n\n\n\n
\n
\n
Award Handbook<\/a><\/div>\n<\/div>\n<\/div>\n\n\n\n
\n
\n
Past Award Recipients<\/a><\/div>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n
\n\n\n\n

Eligibility<\/span><\/strong><\/p>\n\n\n\n